30 years of historical data (1996–2025) · Healthcare · Medical - Distribution
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Henry Schein, Inc. trades at 24.4x earnings, 13% above its 5-year average of 21.6x, sitting at the 89th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 10%. On a free-cash-flow basis, the stock trades at 16.0x P/FCF, 18% below the 5-year average of 19.4x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.2B | $9.3B | $9.0B | $10.0B | $11.0B | $11.0B | $9.6B | $10.0B | $9.5B | $8.7B | $9.7B |
| Enterprise Value | $12.7B | $12.8B | $11.7B | $12.5B | $12.4B | $12.1B | $10.2B | $10.9B | $11.3B | $10.2B | $10.8B |
| P/E Ratio → | 24.44 | 23.28 | 23.09 | 23.96 | 20.43 | 17.42 | 23.88 | 19.62 | 17.65 | 21.33 | 19.07 |
| P/S Ratio | 0.70 | 0.70 | 0.71 | 0.81 | 0.87 | 0.89 | 0.95 | 1.00 | 0.72 | 0.70 | 0.83 |
| P/B Ratio | 2.03 | 1.93 | 1.86 | 1.94 | 2.36 | 2.35 | 2.22 | 2.54 | 2.46 | 2.37 | 2.83 |
| P/FCF | 16.00 | 16.17 | 13.61 | 28.26 | 21.74 | 17.43 | 17.43 | 17.23 | 15.93 | 18.69 | 17.72 |
| P/OCF | 12.88 | 13.01 | 10.61 | 19.95 | 18.28 | 15.49 | 16.01 | 15.22 | 13.82 | 15.90 | 15.70 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Henry Schein, Inc.'s enterprise value stands at 11.9x EBITDA, roughly in line with its 5-year average of 11.7x. The Healthcare sector median is 14.2x, placing the stock at a 16% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.97 | 0.93 | 1.02 | 0.98 | 0.97 | 1.00 | 1.09 | 0.86 | 0.82 | 0.93 |
| EV / EBITDA | 11.88 | 11.97 | 11.45 | 13.04 | 10.77 | 11.36 | 13.51 | 11.82 | 13.56 | 9.61 | 10.96 |
| EV / EBIT | 16.76 | 18.41 | 18.24 | 19.94 | 16.19 | 14.09 | 18.79 | 14.84 | 18.52 | 11.59 | 13.73 |
| EV / FCF | — | 22.33 | 17.77 | 35.54 | 24.47 | 19.17 | 18.49 | 18.78 | 19.10 | 21.90 | 19.84 |
Margins and return-on-capital ratios measuring operating efficiency
Henry Schein, Inc. earns an operating margin of 5.7%. ROE of 8.3% is modest. ROIC of 7.1% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.1% | 29.1% | 29.7% | 29.6% | 28.9% | 29.6% | 27.8% | 31.0% | 22.0% | 27.3% | 27.9% |
| Operating Margin | 5.7% | 5.7% | 5.8% | 5.8% | 7.4% | 6.9% | 5.6% | 7.3% | 5.3% | 6.9% | 7.1% |
| Net Profit Margin | 3.0% | 3.0% | 3.1% | 3.4% | 4.3% | 5.0% | 4.0% | 5.1% | 4.1% | 3.3% | 4.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.3% | 8.3% | 7.8% | 8.5% | 11.5% | 13.9% | 9.8% | 13.1% | 14.3% | 11.5% | 14.8% |
| ROA | 3.7% | 3.7% | 3.8% | 4.3% | 6.3% | 7.7% | 5.4% | 6.5% | 6.5% | 5.6% | 7.6% |
| ROIC | 7.1% | 7.1% | 7.1% | 7.8% | 11.9% | 12.0% | 8.8% | 10.4% | 9.6% | 13.4% | 14.0% |
| ROCE | 9.8% | 9.8% | 9.5% | 10.0% | 14.9% | 14.7% | 10.7% | 14.1% | 13.4% | 18.3% | 18.6% |
Solvency and debt-coverage ratios — lower is generally safer
Henry Schein, Inc. carries a Debt/EBITDA ratio of 3.4x, which is moderately leveraged (7% above the sector average of 3.2x). Net debt stands at $3.5B ($3.7B total debt minus $156M cash). Interest coverage of 4.6x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 0.77 | 0.59 | 0.53 | 0.32 | 0.26 | 0.23 | 0.25 | 0.50 | 0.46 | 0.36 |
| Debt / EBITDA | 3.45 | 3.45 | 2.80 | 2.85 | 1.30 | 1.14 | 1.33 | 1.09 | 2.32 | 1.58 | 1.23 |
| Net Debt / Equity | — | 0.74 | 0.57 | 0.50 | 0.30 | 0.24 | 0.13 | 0.23 | 0.49 | 0.41 | 0.34 |
| Net Debt / EBITDA | 3.30 | 3.30 | 2.68 | 2.67 | 1.20 | 1.03 | 0.77 | 0.97 | 2.25 | 1.41 | 1.17 |
| Debt / FCF | — | 6.16 | 4.16 | 7.28 | 2.73 | 1.74 | 1.06 | 1.54 | 3.17 | 3.21 | 2.12 |
| Interest Coverage | 4.63 | 4.63 | 4.92 | 7.23 | 17.39 | 31.09 | 13.08 | 14.39 | 8.06 | 16.34 | 24.70 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.38x means Henry Schein, Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.76x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.67x to 1.38x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | 1.38 | 1.42 | 1.67 | 1.79 | 1.67 | 1.66 | 1.58 | 1.30 | 1.44 | 1.44 |
| Quick Ratio | 0.76 | 0.76 | 0.78 | 1.00 | 0.91 | 0.86 | 1.00 | 0.88 | 0.86 | 0.76 | 0.72 |
| Cash Ratio | 0.05 | 0.05 | 0.04 | 0.06 | 0.05 | 0.05 | 0.18 | 0.05 | 0.02 | 0.06 | 0.03 |
| Asset Turnover | — | 1.18 | 1.24 | 1.17 | 1.47 | 1.46 | 1.30 | 1.40 | 1.55 | 1.58 | 1.71 |
| Inventory Turnover | 4.67 | 4.67 | 4.92 | 4.79 | 4.58 | 4.69 | 4.83 | 4.83 | 4.60 | 4.69 | 5.01 |
| Days Sales Outstanding | — | 45.71 | 42.68 | 55.11 | 41.62 | 42.74 | 51.39 | 45.55 | 32.31 | 44.60 | 39.56 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Henry Schein, Inc. returns 9.3% to shareholders annually primarily through share buybacks. The earnings yield of 4.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.1% | 4.3% | 4.3% | 4.2% | 4.9% | 5.7% | 4.2% | 5.1% | 5.7% | 4.7% | 5.2% |
| FCF Yield | 6.2% | 6.2% | 7.3% | 3.5% | 4.6% | 5.7% | 5.7% | 5.8% | 6.3% | 5.4% | 5.6% |
| Buyback Yield | 9.3% | 9.2% | 4.3% | 2.8% | 4.4% | 3.6% | 0.9% | 5.3% | 2.1% | 5.2% | 5.7% |
| Total Shareholder Yield | 9.3% | 9.2% | 4.3% | 2.8% | 4.4% | 3.6% | 0.9% | 5.3% | 2.1% | 5.2% | 5.7% |
| Shares Outstanding | — | $122M | $128M | $132M | $138M | $142M | $143M | $149M | $154M | $158M | $162M |
Compare HSIC with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $9B | 24.4 | 11.9 | 16.0 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 | |
| $3B | 32.4 | 15.6 | 49.9 | 31.5% | 8.8% | 19.3% | 12.5% | 4.6 | |
| $171M | -0.2 | 1.7 | — | — | 1.0% | -2111.6% | 1.8% | 2.6 | |
| $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 | |
| $52B | 34.4 | 18.8 | 28.2 | 3.7% | 1.0% | — | 3378.7% | 3.0 | |
| $2B | -3.4 | 7.0 | 19.9 | 50.0% | 6.8% | -36.4% | 5.1% | 4.1 | |
| $13B | 32.2 | 15.2 | 26.6 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 | |
| $4B | 92.5 | 13.8 | 18.3 | 55.0% | 8.3% | 1.6% | 4.8% | 5.0 | |
| $51M | -0.8 | — | — | 29.0% | -8.3% | -72.8% | -39.3% | — | |
| $11B | 20.2 | 17.1 | 18.1 | 67.4% | 16.3% | 12.3% | 8.9% | 0.2 | |
| $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HSIC stock.
Henry Schein, Inc.'s current P/E ratio is 24.4x. The historical average is 21.3x. This places it at the 89th percentile of its historical range.
Henry Schein, Inc.'s current EV/EBITDA is 11.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 14.0x.
Henry Schein, Inc.'s return on equity (ROE) is 8.3%. The historical average is 11.6%.
Based on historical data, Henry Schein, Inc. is trading at a P/E of 24.4x. This is at the 89th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Henry Schein, Inc. has 29.1% gross margin and 5.7% operating margin.
Henry Schein, Inc.'s Debt/EBITDA ratio is 3.4x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.